Kewaunee Scientific (KEQU) Liabilities and Shareholders Equity (2016 - 2026)
Kewaunee Scientific (KEQU) has 15 years of Liabilities and Shareholders Equity data on record, last reported at $189.1 million in Q4 2025.
- For Q4 2025, Liabilities and Shareholders Equity rose 40.6% year-over-year to $189.1 million; the TTM value through Oct 2025 reached $766.4 million, up 45.26%, while the annual FY2025 figure was $194.7 million, 44.44% up from the prior year.
- Liabilities and Shareholders Equity reached $189.1 million in Q4 2025 per KEQU's latest filing, down from $193.5 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $194.7 million in Q2 2025 and bottomed at $89.4 million in Q2 2021.
- Average Liabilities and Shareholders Equity over 5 years is $132.1 million, with a median of $124.8 million recorded in 2023.
- Peak YoY movement for Liabilities and Shareholders Equity: dropped 0.66% in 2023, then surged 49.75% in 2025.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $90.3 million in 2021, then surged by 31.92% to $119.1 million in 2022, then grew by 2.17% to $121.7 million in 2023, then grew by 10.49% to $134.5 million in 2024, then skyrocketed by 40.6% to $189.1 million in 2025.
- Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $189.1 million in Q4 2025, $193.5 million in Q3 2025, and $194.7 million in Q2 2025.